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Abstract IgE response specific to those molecular regions of
casein that contain a major phosphorylation site was analyzed
using native and modified caseins and derived peptides. This
study included (i) the naturally occurring common variants A1
and A from L- and Ks2-caseins, respectively, which were purified
in the native form and then dephosphorylated, (ii) a purified rare
variant D of Ks2-casein which lacks one major phosphorylation
site, and (iii) the native and dephosphorylated tryptic fragment
f(1^25) from L-casein. Direct and indirect ELISA using sera
from patients allergic to milk showed that the IgE response to
caseins is affected by modifying or eliminating the major
phosphorylation site.
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1. Introduction
The functional properties of proteins are modulated by nu-
merous post-translational modi¢cations that act directly or
in£uence the secondary^tertiary folding of the molecule.
Such post-translational processes also in£uence the immuno-
reactivity of proteins and especially of allergens, which are
mostly glycoproteins, where the deglycosylation lowers immu-
noreactivity [1,2]. Glycosylation is not the only post-transla-
tional event a¡ecting protein allergenicity [3].
Much e¡ort has been devoted to identifying the domains
responsible for the allergenic potential of allergens. To localize
mainly the linear epitopes, a logical approach consists in using
peptides, either prepared by chemical synthesis or resulting
from enzymatic hydrolysis. Recently, recombinant allergens
subject to deletions or substitutions were obtained for various
molecules, including calcium binding proteins, and proved
helpful in identifying IgE binding domains (linear and/or con-
formational epitopes) for pollen [4^6] and peanut [7]. How-
ever, the IgE immunoreactivity of recombinant allergens may
be lower than that of natural molecules, probably due to a
de¢ciency in the post-translational events [8].
In cow’s milk, whole casein accounts for 80% of the total
protein content and presents an interesting post-translational
feature, i.e. phosphorylation of some residues involved in
Ca2 binding. This occurs in three out of four of its constit-
uents (i.e. L-, Ks1- and Ks2-casein). These caseins can exhibit
di¡erent degrees of phosphorylation, the phosphorylated seryl
residues being mostly grouped together in major phosphory-
lation sites.
In previous studies, we have demonstrated that whole ca-
sein acts as a potent allergen in cow’s milk allergy and that
each of the di¡erent casein fractions (L-, Ks1-, Ks2- and U-
casein) can induce a marked IgE response [9]. Co- and/or
cross-sensitization to the di¡erent caseins was observed in
most cow’s milk allergic patients, suggesting that both distinct
and common epitopes may occur on these proteins. These
di¡erent caseins, encoded by four di¡erent genes, have very
few amino acid sequence homologies [10,11]. A rare homolo-
gous sequence present in the three Ca2 binding caseins is the
highly conserved major site of phosphorylation, i.e. SerP-
SerP-SerP-Glu-Glu corresponding to sequences (66^70) of
Ks1-casein, (17^21) of L-casein, (8^12) and (56^60) of Ks2-
casein [12].
Modi¢cation of such a well-characterized site in casein thus
appeared to be an original way to characterize an important
epitope. This strategy bene¢ts from the natural occurrence in
milk proteins of di¡erent genetic variants with substitution(s)
and/or deletion(s) [13].
The in£uence of phosphorylation on the immunoreactivity
of the Ca2 binding caseins was studied using either IgG from
immunized animals or IgE from sera of allergic patients as a
marker. The reactivity of these Ig isotypes was studied on
various forms of puri¢ed bovine caseins (native, enzymatically
dephosphorylated, or constitutively deleted for the phosphor-
ylation site), and on the native and dephosphorylated form of
the L-casein fragment 1^25 which comprises the cluster se-
quence of phosphorylated serine residues [14].
2. Materials and methods
2.1. Sera
Human sera from patients with clinical symptoms of cow’s milk
allergy were obtained from hospital banks of sera. These sera were
tested for speci¢c anti-bovine L- and Ks2-casein IgE using the original
enzyme immunoassay (EIA) developed in our laboratory [9]. Fifty-
three sera with a large range of speci¢c IgE were thus selected for the
study. The concentrations of speci¢c IgE ranged from 0.1 to 330 IU/
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ml (i.e. 0.2^750 ng/ml). Eight control sera were obtained from non-
allergic human volunteers.
2.2. Puri¢cation of di¡erent variants from Ks2- and L-casein
Variant A1 from L-casein and variants A and D from Ks2-casein
were prepared from fresh milk samples of cows that were homozygous
for these variants. These cows were identi¢ed and selected among
genetically typed individuals listed in the records of the herd book
of the Holstein (for L-casein variant A1 and Ks2-casein variant A) and
Tarine breeds (for Ks2-casein variant D). Whole casein containing
Ks2-casein variant D was obtained by precipitation at pH 4.6 and
selectively fractionated by addition of 40% propanol-1 at 4‡C. After
2 h of slight agitation, the mixture was centrifuged at 17 000 rpm for
30 min at 4‡C. The supernatant was discarded and the precipitate was
solubilized in 6 M urea, dialyzed against water adjusted to pH 7.0
with NaOH, and lyophilized. Puri¢cation was achieved using a
MonoQ anion exchange system [9]. Ks2-Casein variant A and L-casein
variant A1 were puri¢ed by selective precipitations followed by anion
exchange chromatography as previously described [9].
2.3. Dephosphorylation of L- and Ks2-casein
Native L-casein variant A1 was dissolved (10 mg/ml) in 50 mM
sodium acetate bu¡er pH 5.8 (1% w/v) before adding potato acid
phosphatase at a 1/500 (w/w) enzyme/substrate (E/S) ratio [15]. Ks2-
Casein variant A (15 mg/ml) was reacted in 50 mM sodium citrate
bu¡er pH 7.5 with the same enzyme using a 1/30 (w/w) E/S ratio. The
reaction was allowed to proceed for 20 h at 30‡C for L-casein and for
30 h at 37‡C for Ks2-casein in a dialysis bath to dilute inorganic
phosphate, which could inhibit the enzyme. In both cases, the pH
of the solution was adjusted to 10 to inactivate the enzyme before
dialysis against water (adjusted to pH 7.4 with 0.1 M NaOH) and
lyophilization. Dephosphorylated forms were isolated by anion ex-
change chromatography [9].
2.4. Purity of the native and dephosphorylated caseins
Purity of the bovine caseins was assessed by reverse phase high
performance liquid chromatography (RP-HPLC) using a C4-Vydac
250U4.6 mm column (Shandon). Elution was performed with a 40
min linear gradient from 25 to 45% of bu¡er B (acetonitrile^0.04%
tri£uoroacetic acid (TFA)) in bu¡er A (H2O^0.1% TFA) at a £ow
rate of 1 ml/min. Detection was at 220 nm. The purity and immuno-
reactivity of the di¡erent native and dephosphorylated caseins were
investigated by enzyme-linked immunosorbent assay (ELISA) as pre-
viously described [9,16]. Speci¢c animal antisera were raised against
Ks1-, Ks2-, U-caseins and L-lactoglobulin in rabbit and against L-ca-
sein in guinea pig. Antisera were obtained by immunizing animals
with each puri¢ed native protein. Since caseins are poorly immuno-
genic, they were ¢rst cross-linked using glutaraldehyde. Each animal
was then ¢rst injected with 50 Wg of each casein polymer using com-
plete Freund’s adjuvant, then boosted every 2 weeks in the presence of
incomplete Freund’s adjuvant.
2.5. Preparation and puri¢cation of the native and dephosphorylated
fragment f(1^25) from L-casein
A three-step procedure consisting of solid phase extraction (anion
exchange cartridges, QMA), RP-HPLC (C18) and anion exchange
chromatography (QMA) was used to isolate casein phosphopeptide
f(1^25)4P from a tryptic hydrolysate of bovine casein as described in
[17]. An immobilized alkaline phosphatase (F7m column, Mobitec)
was used for the preparation of the dephosphorylated fragment [17].
Purity of the isolated peptides was checked by analytical RP-HPLC
(C18) and amino acid analysis [17], as well as by determination of the
N-terminal group by the dansyl chloride method according to [18].
2.6. Phosphate determination
Phosphate groups were released from caseins by acid and heat
treatments [19]. Phosphate groups were determined as inorganic phos-
phates by a colorimetric method in a microtiter plate assay [20] based
on the formation of a complex between phosphomolybdate and mal-
achite green using previously described reagents [21,22]. The phos-
phorylation of caseins was compared with a standard curve obtained
using known amounts of phosphoserine.
2.7. Speci¢c IgE ELISA
Speci¢c IgE ELISA was performed as previously described [9,16].
Brie£y, 96-well microplates (Nunc) were coated with 200 Wl of puri¢ed
protein or peptide (5 Wg/ml) in 0.025 M ethylenediaminetetraacetic
acid (EDTA) carbonate bu¡er pH 9.3. The plates were incubated
for 18 h at 4‡C and further saturated for 18 h at +4‡C with 300 Wl
of EIA bu¡er (0.1 M potassium phosphate bu¡er pH 7.4 containing
0.1% human serum albumin (HSA), 0.4 M NaCl, 0.001 M EDTA and
0.01% sodium azide). Just before use, the plates were washed in an
automatic plate washer (Titertek) with 0.01 M potassium phosphate
bu¡er pH 7.4 containing 0.05% Tween 20.
Sera from allergic patients (50 Wl) were dispensed per well at an
appropriate dilution. After reaction for 24 h at 20‡C followed by
extensive washing, 50 Wl/well of a solution of an anti-human IgE
mouse monoclonal antibody (mAb) (i.e. clone BS17) labelled with
acetylcholinesterase (AChE) was added. After a further 18-h incuba-
tion at 20‡C, the plates were washed before revealing bound AChE by
addition of 200 Wl/well of Ellman reagent [23]. The enzymatic reaction
was monitored at 414 nm using a Titertek plate reader.
Eight sera from non-allergic patients were used as negative controls.
Non-speci¢c binding was also evaluated by dispensing positive sera
into HSA-coated wells.
Speci¢c IgE were quanti¢ed as already described [16]. No interfer-
ence with speci¢c IgG was observed. The detection limit of speci¢c
IgE, calculated as the concentration corresponding to the average
non-speci¢c binding plus 3 standard deviations, was approximately
0.1 IU/ml (i.e. 0.23 ng/ml).
2.8. Indirect IgE ELISA
According to the amount of speci¢c IgE measured in individual
patients, sera were selected for complementary competitive ELISA.
Immune or control sera (50 Wl) were ¢rst incubated for 6 h by mixing
at 20‡C with 50 Wl of increasing concentrations of inhibitors (ranging
from 0.001 to 4 nmol/ml for caseins and 0.01 to 10 Wg/ml for peptides)
in EIA bu¡er. HSA was used as a control to evaluate the non-speci¢c
binding at high inhibitor concentrations. Aliquots (50 Wl) of the mix-
ture were then added to the antigen-coated wells. The di¡erent steps
of the assay were then performed as described above.
3. Results
3.1. Puri¢cation and characterization of the dephosphorylated
L- and Ks2-caseins
Enzymatic dephosphorylation of puri¢ed Ks2-casein variant
A and L-casein variant A1 was checked by fast protein liquid
chromatography (FPLC). In both cases, numerous peaks were
observed. Late eluting minor peaks corresponding to native
caseins (namely Ks2- and L-casein) were detected. Inversely,
the major peak corresponding to the most dephosphorylated
form was poorly retained by anion exchange chromatography.
In each case, the major peak was collected and characterized.
Absence of contamination of the dephosphorylated caseins
by native forms was checked by RP-HPLC. Chromatographic
patterns of both the native and the isolated dephosphorylated
forms of the L- and Ks2-caseins are shown in Fig. 1A,B. Each
of the dephosphorylated caseins was eluted at a di¡erent re-
tention time than its native counterpart. Due to the elimina-
tion of the phosphate groups, the dephosphorylated fractions
were more hydrophobic and thus had higher retention times
than the native forms. However, dephosphorylated Ks2-casein
showed a minor peak which could correspond to the native
form. This possible contamination was estimated to be less
than 5%.
Phosphate determination revealed 1.6 nmol of phosphate
for 0.32 nmol of native L-casein while no phosphate group
was detected after dephosphorylation. On the other hand, a
signi¢cant concentration of phosphate (two phosphate groups
per molecule) was found in the puri¢ed dephosphorylated
Ks2-casein. This could result either from a contamination by
the native form (see above) or from a resistance of some
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groups to enzymatic degradation. However, these two residual
phosphate groups represent less than 20% of the initial phos-
phate content of the native molecule, thus demonstrating the
e⁄cient action of the phosphatase.
3.2. Puri¢cation and characterization of the deleted Ks2-casein
variant D
After selective precipitation, FPLC revealed marked hetero-
geneity of the deleted Ks2-casein (data not shown). The major
peak was collected and analyzed by RP-HPLC, demonstrating
the absence of contamination by the other caseins (i.e. U-, Ks1-
and L-caseins). These results were con¢rmed by immunoana-
lytical methods, using speci¢c antisera raised against each of
these di¡erent caseins.
3.3. Puri¢cation and characterization of native and
dephosphorylated fragment f(1^25) from L-casein
The three-step procedure separates phosphopeptides and
non-phosphorylated peptides [17]. The yield of L-casein f(1^
25)4P from 240 mg of lyophilized soluble fraction of a tryptic
hydrolysate of bovine casein was 3.3 mg. After enzymatic
dephosphorylation of 18.1 mg of L-casein f(1^25)4P collected
from several puri¢cation runs, the yield of the dephosphory-
lated fragment L-casein f(1^25)0P was 11.7 mg. The peptides
were clearly identi¢ed by determination of amino acid com-
position, phosphorus content and N-terminal end group.
3.4. IgG binding capacity of the di¡erent caseins
Competitive ELISA was performed using speci¢c polyclon-
al anti-L- and anti-Ks2-casein antibodies raised against each of
the puri¢ed caseins. No di¡erence was observed between the
native and dephosphorylated forms of L-casein in the inhibi-
tion of the binding of speci¢c guinea pig anti-L-casein poly-
clonal antibodies to immobilized native L-casein.
The same phenomenon was also observed in inhibition
studies with Ks2-casein, using native Ks2-casein-coated plates.
Dephosphorylated as well as deleted forms of the protein
appeared as e⁄cient as the native variant A counterpart in
inhibiting the binding of speci¢c rabbit anti-Ks2-casein poly-
clonal antibodies. In the case of L- and Ks2-caseins, all the
inhibition curves obtained with the di¡erent forms of the pro-
teins were identical.
3.5. IgE binding capacity of native and dephosphorylated
L-casein and fragments
Using direct ELISA in microplates coated with either native
or dephosphorylated bovine L-casein, 53 sera from patients
allergic to L-casein were analyzed for speci¢c IgE against
both forms of the protein. In all sera, the IgE response to
dephosphorylated L-casein was lower than that to native
L-casein. In particular, four sera showed no IgE response to
dephosphorylated L-casein while 15 others exhibited a two-
fold lower IgE response. In 15 sera, the IgE response to de-
phosphorylated L-casein was 25^40% lower than to the native
molecule. For the last 19 sera, the intensity of the IgE re-
sponse to dephosphorylated L-casein was 80^100% of the re-
sponse to native L-casein.
Competitive ELISA was performed on six sera selected
Fig. 1. RP-HPLC chromatograms of the di¡erent puri¢ed caseins:
(A) native and dephosphorylated Ks2-casein (in bold); (B) native
and dephosphorylated L-casein (in bold). Detection at 220 nm is ex-
pressed in absorbance units (A.U.). Concentration of bu¡er B is ex-
pressed in % (%B).
Fig. 2. Indirect ELISA. Inhibition of the binding of speci¢c anti-L-
casein (L-CN) IgE to immobilized native L-CN by phosphorylated
(F) and dephosphorylated L-CN (a). B and Bo represent the bound
enzyme activity measured in the presence or absence of inhibitor, re-
spectively. The results are expressed in terms of B/Bo as a function
of the logarithm of the dose.
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from those showing a high IgE response to native L-casein.
The dephosphorylated form always signi¢cantly inhibited IgE
binding to native L-casein. For two sera, similar inhibition
curves were obtained for native and dephosphorylated L-ca-
sein. However, for the four other sera, dephosphorylation
induced a loss of recognition. Concentrations of dephosphor-
ylated L-casein up to ¢ve-fold higher than those of the native
form were needed to obtain the same inhibition (i.e. 50%) of
the binding, as shown in Fig. 2 for one representative serum.
Moreover, the same observations were made on the isolated
amino-terminal part of the protein using four sera which ex-
hibited strong IgE binding to immobilized fragment f(1^25) of
L-casein. IgE binding inhibition by dephosphorylated frag-
ment f(1^25) was greatly limited when compared to the
phosphorylated peptide. This is shown in Fig. 3 for one serum
for which competition was totally absent using the dephos-
phorylated fragment.
3.6. IgE binding capacity of the di¡erent forms from Ks2-casein
Direct ELISA was used to test 29 sera positive to variant A
of Ks2-casein for their IgE response to immobilized variant D
of Ks2-casein. Absence of IgE response to deleted Ks2-casein
was only observed for one serum. Comparison of IgE levels
obtained with both variants revealed a great heterogeneity of
the response. For most sera, the recognition of these two
forms was not equivalent. However, as many sera exhibited
a higher response to the variant A as to the deleted variant D.
This was particularly evident when the IgE response to deleted
Ks2-casein was expressed as a percentage of the IgE response
to the non-deleted form, showing a Gaussian distribution with
a median close to 100%.
Indirect ELISA using immobilized variant A was used to
test the immunoreactivity of the di¡erent forms of Ks2-casein.
IgE binding could be partially or completely inhibited by each
of the three di¡erent forms of Ks2-caseins. However, these
experiments show a range in the e⁄ciency of inhibition ob-
tained with these three forms. The non-deleted variant A al-
ways appears a better competitor than deleted variant D. As
far as totally dephosphorylated Ks2-casein is concerned, huge
amounts are required to inhibit the IgE binding. This was
particularly striking with four sera where 6^30-fold more
Ks2-casein variant D and 50-fold more dephosphorylated
Ks2-casein than variant A was necessary to reach the same
binding inhibition (IC50). Typical inhibitions are shown in
Fig. 4.
4. Discussion
Small et al. [24] found that 80% of the phosphorylation sites
were in L-turn predicted regions. Major phosphorylation sites
in bovine caseins are hydrophilic and correspond to a loop
structure which could include only L-turn as regular second-
ary structure [25]. The occurrence of L-turn in a phosphopep-
tide from casein was also described by Huq et al. [26], while
Wahlgren et al. showed that phosphopeptide from L-casein is
highly £exible [27]. These di¡ering characteristics of primary
and secondary structures were in accordance with predictions
of immunogenic and/or antigenic domains [28^30]. Further-
more, the immunoreactivity of caseinophosphopeptides could
result from their liberation during intestinal proteolysis and
their resistance to further degradation by digestive enzymes
[31].
We used genetically deleted variants and chemically modi-
¢ed forms of caseins to evaluate the in£uence of post-transla-
tional modi¢cations, such as phosphorylation, on the immu-
noreactivity of the caseins. Potato acid phosphatase was used
to dephosphorylate L- and Ks2-casein as previously described
for L- and Ks1-casein [15,32,33]. Total dephosphorylation of
Ks2-casein was more di⁄cult. Our preliminary studies showed
that yeast alkaline phosphatase was ine⁄cient and SDS^
Fig. 3. Indirect ELISA. Inhibition of the binding of speci¢c anti-L-
casein (L-CN) IgE to immobilized fragment f(1^25) from native
L-CN by phosphorylated (F) and dephosphorylated (O) fragments
f(1^25) from L-CN. B and Bo represent the bound enzyme activity
measured in the presence or absence of inhibitor, respectively. The
results are expressed in terms of B/Bo as a function of the loga-
rithm of the dose.
Fig. 4. Indirect ELISA. Inhibition of the binding of speci¢c anti-
Ks2-casein (Ks2-CN) IgE to immobilized native Ks2-CN variant A
by phosphorylated Ks2-casein variant A (F), deleted Ks2-casein var-
iant D (E) and dephosphorylated Ks2-casein variant A (a). B and
Bo represent the bound enzyme activity measured in the presence or
absence of inhibitor, respectively. The results are expressed in terms
of B/Bo as a function of the logarithm of the dose.
FEBS 23310 3-2-00
H. Bernard et al./FEBS Letters 467 (2000) 239^244242
PAGE demonstrated the presence of degradation products
(data not shown). We therefore decided to dephosphorylate
Ks2-casein with acid phosphatase under drastic conditions:
pH 7.5 to avoid precipitation of the casein [34] and an un-
usual E/S ratio to compensate for the reduced enzyme activity
at this pH [32].
As expected, dephosphorylated Ks2- and L-casein eluted
more rapidly in FPLC anion exchange chromatography
than the native forms [35]. Dephosphorylated forms can
also be distinguished from native caseins by RP-HPLC anal-
ysis, where the loss of hydrophilic groups leads to stronger
interactions [15,36]. This was also veri¢ed for variant D of
Ks2-casein which lacks sequence 51^59, which includes a ma-
jor phosphorylation site [37,38]. However, chromatographic
behavior during anion exchange chromatography was more
complex. The enriched fraction of Ks2-casein variant D gave
a heterogeneous chromatographic pattern independently of
contamination with other caseins, perhaps due to the presence
of di¡erent isoforms of this variant.
Using speci¢c animal antisera raised against the isolated
whole native molecule of each of the pure casein fractions,
we observed no signi¢cant modi¢cation of the immunoreac-
tivity of L- and Ks2-casein, either after dephosphorylation or
after deletion of a major phosphorylation site. This demon-
strated that no drastic structural change occurs after removal
of phosphate groups and that most of the polyclonal anti-
bodies speci¢cally raised against pure Ks2- and L-casein
were not directed against the major phosphorylation site
and were not a¡ected by the phosphorylation of serine resi-
dues. Moreover, the immunoreactivity of casein seems unaf-
fected by any conformational change induced by reducing the
phosphorylation.
This ¢nding raised the question of the possible involvement
of such a highly conserved sequence as a common cross-re-
active epitope for IgE from patients allergic to caseins.
Interestingly, the same four human sera used in the two sets
of experiments involving L- and Ks2-casein gave similar re-
sults. Dephosphorylation or deletion led to decreased recog-
nition of each casein by the IgE of these four sera. Compar-
ison of the results obtained in the direct vs. competitive
inhibition ELISA suggests that dephosphorylation very likely
lowers the a⁄nity of IgE for caseins rather than the speci¢c
IgE titer itself. Without underestimating the possible confor-
mational change induced by these modi¢cations, it is very
likely that at least part of the anti-casein IgE is directed
against domains comprising a major phosphorylation site.
This is supported by the fact that peptide f(1^25) from
L-casein was less well recognized by IgE after dephosphoryla-
tion. High immunoreactivity of a major phosphorylation site
then appears to be a potential explanation for the cross-reac-
tivity between caseins (as previous studies have suggested) [9].
This agrees with the work of Otani et al. [39] demonstrating
that polyclonal anti-Ks1-casein antibodies cross-react with
L-casein and that the antigenicity of Ks1-casein was lost after
dephosphorylation. Furthermore, cross-reactivity between
Ks2- and Ks1-caseins was also reported with an anti-Ks2-ca-
sein monoclonal antibody [40]. In the same study, binding of
this monoclonal anti-Ks2-casein antibody to Ks2-casein parti-
ally depended on its degree of phosphorylation.
Although the involvement of a major phosphorylation site
as an allergenic epitope could lead to IgE cross-reactivity be-
tween caseins, the possible extension of this cross-reactivity to
other proteins containing this domain remains to be investi-
gated. On the other hand, the potential allergenicity of casein-
ophosphopeptides should be taken into account when consid-
ering their biological interest and possible use in functional
foods [41].
In conclusion, the major phosphorylation site appears to be
an important allergenic epitope in caseins, and its alteration
will a¡ect the allergenicity of the caseins. In the case of milk
allergy, milk protein variants, especially deleted isoforms
which naturally exist in cow’s and goat’s milk, would be val-
uable in epitope mapping and investigation of the impact of
structural post-translational modi¢cations on allergy.
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